نتایج جستجو برای: inhaled budesonide

تعداد نتایج: 18299  

Journal: :The European respiratory journal 1989
T Engel J H Heinig O Madsen M Hansen E R Weeke

The aim of the present randomized, double-blind study was to evaluate the effect of inhaled budesonide on daily symptoms, ventilatory capacity, and airway responsiveness in smokers with chronic bronchitis. Twenty-five subjects with a provocative concentration producing a 20% fall in forced expiratory volume in one second PC20(FEV1) less than 2.0 mg.ml-1, by bronchial histamine challenge, were i...

Journal: :European annals of allergy and clinical immunology 2012
D Machado C Pereira B Tavares G Loureiro A Segorbe-Luís

BACKGROUND Inhaled combined therapy improves the pulmonary function in asthmatic patients. The effect on the airway hyperresponsiveness (AHR) and the efficacy of different pharmacological schedules is not well clarified on adolescent asthmatics. OBJECTIVE Evaluate the responses to different combined inhaled therapies in adolescent asthmatics and study its impact on exercise induced AHR. MET...

Journal: :Chest 2002
Shinji Teramoto Haruki Kume Yasuyochi Ouchi

cortisol deficiency associated with low-dose corticosteroid therapy for asthma. Pediatrics 1996; 97:921–923 7 Tabachnik E, Zadik Z. Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma. We thank Doctors Caballero-Fonseca and Sanchez-Borges for their interest in our abstract (October 2001 supplement). 1 We reported on a large case series of p...

Journal: :The European respiratory journal 2010
L E Donnelly S J Tudhope P S Fenwick P J Barnes

Pulmonary macrophages are a target for inhaled therapies. Combinations of long-acting beta(2)-agonists (LABA) and glucocorticosteroids have been developed for asthma and chronic obstructive pulmonary disease (COPD). This study examined two LABA, salmeterol and formoterol, and the glucocorticosteroid, budesonide, on cytokine release from monocyte-derived macrophages (MDM) to determine whether an...

Journal: :ACP journal club 2002
Dion Grosser Brian Smith

Patients 1970 patients who were > 12 years of age and had mild asthma. 698 corticosteroid free patients (group A) (mean age 31 y, 60% women) had not used an inhaled corticosteroid for > 3 months and had an FEV1 > 80% of predicted normal after inhaling terbutaline, 1 mg. 1272 corticosteroid treated patients (group B) (mean age 37 y, 57% women) were receiving < 400 ìg/day of inhaled budesonide or...

2013
Qiuhong Fang Nancy A Schulte Huijung Kim Tetsu Kobayashi Xingqi Wang Anna Miller-Larsson Elisabet Wieslander Myron L Toews Xiangde Liu Stephen I Rennard

BACKGROUND The balance between production and degradation of extracellular matrix is crucial in maintaining normal tissue structure. This study was designed to investigate the effect of budesonide on fibroblast-mediated tissue repair and remodeling. METHODS Using human fetal lung fibroblasts in a three-dimensional collagen gel culture system, we investigated the effect of budesonide (1-1000 n...

Journal: :The European respiratory journal 1997
W H Nikolaizik M A Preece J O Warner

Inhaled corticosteroids have become a mainstay in the management of chronic asthma. Their use had been considered safe, although some degree of adrenal suppression has been demonstrated after 2 and 4 weeks of treatment with either 400 microg x day(-1) of beclomethasone dipropionate or budesonide. To weigh the benefits and risks of long-term treatment, 12 children with moderately severe asthma w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید